VOL. XCIV, NO. 247
★ BEST INVESTING TOOLS COMPARISON ★
NO ADVICE
Tuesday, January 6, 2026
Tool Comparison
Dilution Tracker vs InvestorGain comparison
Compare pricing, supported platforms, categories, and standout capabilities to decide which tool fits your workflow.
Comparison highlights
- Tool score: the chart below shows community vote sentiment over the last 8 weeks. Use it as a signal, not a verdict.
- Overlap: both cover Secondary Offerings, and Education.
- Coverage tilt: Dilution Tracker has 2 categories you won't get in InvestorGain; InvestorGain has 5 unique categories.
- Pricing: Dilution Tracker is Free, Subscription; InvestorGain is Free.
Vote sentiment comparison
Cumulative positive vote share. Loading fresh totals...
Side-by-side metrics
| Attribute | Dilution Tracker | InvestorGain |
|---|---|---|
Asset types Supported asset classes and universes | Stocks | Stocks, Bonds |
Experience levels Who each product is built for | Beginner, Intermediate, Advanced | Beginner, Intermediate, Advanced |
Platforms Where you can access the product | Web | Web, Mobile |
Pricing High-level pricing models | Free, Subscription | Free |
Tested Verified by hands-on testing inside Find My Moat | Not yet | Not yet |
Editor pick Featured inside curated shortlists | Standard listing | Standard listing |
Coverage overlap
Shared categories
Categories where both tools offer overlapping coverage.
InvestorGain strengths
Categories covered by InvestorGain but not Dilution Tracker.
Frequently Asked Questions
Which workflows do Dilution Tracker and InvestorGain both support?
Both platforms cover Secondary Offerings, and Education workflows, so you can research those use cases in either tool before digging into the feature differences below.
Do Dilution Tracker and InvestorGain require subscriptions?
Both Dilution Tracker and InvestorGain keep freemium access with optional paid upgrades, so you can trial each platform before committing.
Which tool has mobile access?
InvestorGain ships a dedicated mobile experience, while Dilution Tracker focuses on web or desktop access.
What unique strengths set the two platforms apart?
Dilution Tracker differentiates itself with Dilution profiles focused on US-listed small caps; tracks dilution sources such as shelves, warrants, ATMs and convertibles (custom coverage ~2,500 tickers is referenced in alerts docs)., Shares outstanding (O/S) chart shows historical split-adjusted O/S plus stacked “potential dilution” bars for ATM, S-1 offering, warrants, equity line, and convertible notes/preferred., and Offering readiness: indicates whether a company can offer via a registered shelf or a pending S-1 offering (and notes private placements are possible but rarer)., whereas InvestorGain stands out for Live IPO GMP dashboard for mainboard & SME issues, incl. Kostak and estimated listing price (cap price + GMP)., Real‑time IPO subscription tracker with category splits (RII, NII, QIB) for current issues., and IPO anchor investor allocation reports by year (mainboard & SME)..
Other tools you might like
These profiles share overlapping coverage with both sides of this matchup.
- IPO Watch (ipowatch.in)
Overlap: IPO, Buybacks & Authorizations, and Splits.
IPOBuybacks & AuthorizationsSplits - Fiscal.aiEditor's pickHands-on review
Overlap: Alerts, Calendar, and Splits.
AlertsCalendarSplits - GuruFocusEditor's pickHands-on review
Overlap: Alerts, Calendar, and IPO.
AlertsCalendarIPO - KoyfinEditor's pickHands-on review
Overlap: Alerts, Calendar, and Splits.
AlertsCalendarSplits - Stock AnalysisEditor's pickHands-on review
Overlap: Calendar, IPO, and Splits.
CalendarIPOSplits - Benzinga
Overlap: Alerts, Calendar, and Splits.
AlertsCalendarSplits
Curation & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.